STRS Ohio’s Aura Biosciences AURA Stock Holding History

STRS Ohio’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,300	Closed	-$23K	–	1982
2022 Q3	$23K	Hold	1,300	–	–	﹤0.01%	1914
2022 Q2	$18K	Hold	1,300	–	–	﹤0.01%	1966
2022 Q1	$28K	Hold	1,300	–	–	﹤0.01%	2012
2021 Q4	$22K	Buy	+1,300	New	+$23.2K	﹤0.01%	2101

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

STRS Ohio's AURA Position: Q4 2022 in Review

STRS Ohio sold out of Aura Biosciences (AURA) in Q4 2022, closing a stake of 1,300 shares — an estimated $23K sold.

STRS Ohio first reported a position in AURA in Q4 2021 and held it in 4 quarters. The position peaked at $28K in Q1 2022. 49 funds tracked by Wall St. Rank hold AURA as of Q4 2022.

STRS Ohio reported no remaining Aura Biosciences position as of Q4 2022 after selling out during the quarter.
STRS Ohio sold 1,300 Aura Biosciences shares in Q4 2022, an estimated $23K.
STRS Ohio first reported a position in Aura Biosciences in Q4 2021 and held it in 4 quarters.
STRS Ohio's Aura Biosciences position peaked at $28K in Q1 2022.
49 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2022.

Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.